An assessment of the factors affecting the commercialization of cell-based therapeutics: a systematic review protocol View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2017-12

AUTHORS

David Pettitt, Zeeshaan Arshad, Benjamin Davies, James Smith, Anna French, Doug Cole, Kim Bure, Sue Dopson, David DiGiusto, Jeff Karp, Brock Reeve, Richard Barker, Georg Holländer, David Brindley

ABSTRACT

BACKGROUND: Cellular-based therapies represent a platform technology within the rapidly expanding field of regenerative medicine and are distinct from conventional therapeutics-offering a unique approach to managing what were once considered untreatable diseases. Despite a significant increase in basic science activity within the cell therapy arena, alongside a growing portfolio of cell therapy trials and promising investment, the translation of cellular-based therapeutics from "bench to bedside" remains challenging, and the number of industry products available for widespread clinical use remains comparatively low. This systematic review identifies unique intrinsic and extrinsic barriers in the cell-based therapy domain. METHODS/DESIGN: Eight electronic databases will be searched, specifically Medline, EMBASE (OvidSP), BIOSIS & Web of Science, Cochrane Library & HEED, EconLit (ProQuest), WHOLIS WHO Library Database, PAIS International (ProQuest), and Scopus. Addition to this gray literature was searched by manually reviewing relevant work. All identified articles will be subjected for review by two authors who will decide whether or not each article passes our inclusion/exclusion criteria. Eligible papers will subsequently be reviewed, and key data extracted into a pre-designed data extraction scorecard. An assessment of the perceived impact of broad commercial barriers to the adoption of cell-based therapies will be conducted. These broad categories will include manufacturing, regulation and intellectual property, reimbursement, clinical trials, clinical adoption, ethics, and business models. This will inform further discussion in the review. There is no PROSPERO registration number. DISCUSSION: Through a systematic search and appraisal of available literature, this review will identify key challenges in the commercialization pathway of cellular-based therapeutics and highlights significant barriers impeding successful clinical adoption. This will aid in creating an adaptable, acceptable, and harmonized approach supported by apposite regulatory frameworks and pertinent expertise throughout the respective stages of the adoption cycle to facilitate the adoption of new products and technologies in the industry. More... »

PAGES

120

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s13643-017-0517-4

DOI

http://dx.doi.org/10.1186/s13643-017-0517-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1086339067

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/28651620


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0806", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Information Systems", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/08", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Information and Computing Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell- and Tissue-Based Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Commerce", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cost-Benefit Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Regenerative Medicine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Systematic Reviews as Topic", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Oxford", 
          "id": "https://www.grid.ac/institutes/grid.4991.5", 
          "name": [
            "The Oxford \u2013 UCL Centre for the Advancement of Sustainable Medical Innovation (CASMI), The University of Oxford, Oxford, UK", 
            "Department of Paediatrics, University of Oxford, Oxford, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pettitt", 
        "givenName": "David", 
        "id": "sg:person.01213036105.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01213036105.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of St Andrews", 
          "id": "https://www.grid.ac/institutes/grid.11914.3c", 
          "name": [
            "University of St. Andrews School of Medicine, University of St. Andrews, St. Andrews, UK", 
            "Docherty Gardens, KY7 5GA, Glenrothes, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Arshad", 
        "givenName": "Zeeshaan", 
        "id": "sg:person.01124552417.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01124552417.66"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Cambridge", 
          "id": "https://www.grid.ac/institutes/grid.5335.0", 
          "name": [
            "Orthopedic Surgery Departement, University of Cambridge, Cambridge, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Davies", 
        "givenName": "Benjamin", 
        "id": "sg:person.013276703300.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013276703300.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Oxford", 
          "id": "https://www.grid.ac/institutes/grid.4991.5", 
          "name": [
            "The Oxford \u2013 UCL Centre for the Advancement of Sustainable Medical Innovation (CASMI), The University of Oxford, Oxford, UK", 
            "Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Smith", 
        "givenName": "James", 
        "id": "sg:person.0742155077.68", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0742155077.68"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Oxford", 
          "id": "https://www.grid.ac/institutes/grid.4991.5", 
          "name": [
            "The Oxford \u2013 UCL Centre for the Advancement of Sustainable Medical Innovation (CASMI), The University of Oxford, Oxford, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "French", 
        "givenName": "Anna", 
        "id": "sg:person.0727523176.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0727523176.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Flagship Ventures, Cambridge, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cole", 
        "givenName": "Doug", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Sartorius (Germany)", 
          "id": "https://www.grid.ac/institutes/grid.425849.6", 
          "name": [
            "Sartorius Stedim, G\u00f6ttingen, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bure", 
        "givenName": "Kim", 
        "id": "sg:person.01104354070.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01104354070.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Oxford", 
          "id": "https://www.grid.ac/institutes/grid.4991.5", 
          "name": [
            "Said Business School, University of Oxford, Oxford, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dopson", 
        "givenName": "Sue", 
        "id": "sg:person.01357145116.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01357145116.46"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Stanford University", 
          "id": "https://www.grid.ac/institutes/grid.168010.e", 
          "name": [
            "Division of Cell Transplantation and Regenerative Medicine, University of Stanford, Stanford, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "DiGiusto", 
        "givenName": "David", 
        "id": "sg:person.01214337563.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01214337563.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Harvard\u2013MIT Division of Health Sciences and Technology", 
          "id": "https://www.grid.ac/institutes/grid.413735.7", 
          "name": [
            "Harvard Medical School, Harvard University, Boston, USA", 
            "Brigham and Women\u2019s Hospital, Boston, USA", 
            "Harvard-MIT Division of Health Sciences and Technology, Cambridge, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Karp", 
        "givenName": "Jeff", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Harvard University", 
          "id": "https://www.grid.ac/institutes/grid.38142.3c", 
          "name": [
            "Harvard Stem Cell Institute, Cambridge, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Reeve", 
        "givenName": "Brock", 
        "id": "sg:person.01331422403.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01331422403.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Oxford", 
          "id": "https://www.grid.ac/institutes/grid.4991.5", 
          "name": [
            "Said Business School, University of Oxford, Oxford, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Barker", 
        "givenName": "Richard", 
        "id": "sg:person.0776251776.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0776251776.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University Children\u2019s Hospital Basel", 
          "id": "https://www.grid.ac/institutes/grid.412347.7", 
          "name": [
            "Department of Paediatrics, University of Oxford, Oxford, UK", 
            "Department of Biomedicine, University of Basel and Basel University Children\u2019s Hospital, Basel, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Holl\u00e4nder", 
        "givenName": "Georg", 
        "id": "sg:person.01245453273.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01245453273.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University College London", 
          "id": "https://www.grid.ac/institutes/grid.83440.3b", 
          "name": [
            "The Oxford \u2013 UCL Centre for the Advancement of Sustainable Medical Innovation (CASMI), The University of Oxford, Oxford, UK", 
            "Department of Paediatrics, University of Oxford, Oxford, UK", 
            "Said Business School, University of Oxford, Oxford, UK", 
            "Harvard Stem Cell Institute, Cambridge, USA", 
            "Centre for Behavioral Medicine, UCL School of Pharmacy, University College London, London, UK", 
            "USCF-Stanford Center of Excellence in Regulatory Science and Innovation (CERSI), Stanford, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Brindley", 
        "givenName": "David", 
        "id": "sg:person.0665664476.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0665664476.45"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1098/rstb.2015.0017", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011091196"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.stem.2011.10.010", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011240838"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nbt.3218", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011918031", 
          "https://doi.org/10.1038/nbt.3218"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.b2700", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015745369"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.stem.2010.09.004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022455401"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12896-015-0190-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031812111", 
          "https://doi.org/10.1186/s12896-015-0190-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12896-015-0190-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031812111", 
          "https://doi.org/10.1186/s12896-015-0190-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nbt.3452", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032721348", 
          "https://doi.org/10.1038/nbt.3452"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2217/rme.12.45", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034651790"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.stem.2012.04.018", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036397370"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2217/rme.11.28", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1069333383"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.5966/sctm.2013-0180", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1073577458"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2017-12", 
    "datePublishedReg": "2017-12-01", 
    "description": "BACKGROUND: Cellular-based therapies represent a platform technology within the rapidly expanding field of regenerative medicine and are distinct from conventional therapeutics-offering a unique approach to managing what were once considered untreatable diseases. Despite a significant increase in basic science activity within the cell therapy arena, alongside a growing portfolio of cell therapy trials and promising investment, the translation of cellular-based therapeutics from \"bench to bedside\" remains challenging, and the number of industry products available for widespread clinical use remains comparatively low. This systematic review identifies unique intrinsic and extrinsic barriers in the cell-based therapy domain.\nMETHODS/DESIGN: Eight electronic databases will be searched, specifically Medline, EMBASE (OvidSP), BIOSIS & Web of Science, Cochrane Library & HEED, EconLit (ProQuest), WHOLIS WHO Library Database, PAIS International (ProQuest), and Scopus. Addition to this gray literature was searched by manually reviewing relevant work. All identified articles will be subjected for review by two authors who will decide whether or not each article passes our inclusion/exclusion criteria. Eligible papers will subsequently be reviewed, and key data extracted into a pre-designed data extraction scorecard. An assessment of the perceived impact of broad commercial barriers to the adoption of cell-based therapies will be conducted. These broad categories will include manufacturing, regulation and intellectual property, reimbursement, clinical trials, clinical adoption, ethics, and business models. This will inform further discussion in the review. There is no PROSPERO registration number.\nDISCUSSION: Through a systematic search and appraisal of available literature, this review will identify key challenges in the commercialization pathway of cellular-based therapeutics and highlights significant barriers impeding successful clinical adoption. This will aid in creating an adaptable, acceptable, and harmonized approach supported by apposite regulatory frameworks and pertinent expertise throughout the respective stages of the adoption cycle to facilitate the adoption of new products and technologies in the industry.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s13643-017-0517-4", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1046628", 
        "issn": [
          "2046-4053"
        ], 
        "name": "Systematic Reviews", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "6"
      }
    ], 
    "name": "An assessment of the factors affecting the commercialization of cell-based therapeutics: a systematic review protocol", 
    "pagination": "120", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "b452225cade6e2e101d52639819905bf39792f7eba8b164f0134d220e662be57"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "28651620"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101580575"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s13643-017-0517-4"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1086339067"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s13643-017-0517-4", 
      "https://app.dimensions.ai/details/publication/pub.1086339067"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T12:40", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000363_0000000363/records_70049_00000002.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1186%2Fs13643-017-0517-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s13643-017-0517-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s13643-017-0517-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s13643-017-0517-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s13643-017-0517-4'


 

This table displays all metadata directly associated to this object as RDF triples.

255 TRIPLES      21 PREDICATES      46 URIs      27 LITERALS      15 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s13643-017-0517-4 schema:about N078f68aaa9f644889b705a07f7130d61
2 N63b85c25bdac48ec91efe53c832f0b33
3 N7a03df0ffd634a02946c2a6f888398eb
4 N89928ef9038846f98a0ead607075ab68
5 Na62f324d1ff34757a65d792d27bf9a20
6 Nbaae566006294f059f650e40dd314855
7 anzsrc-for:08
8 anzsrc-for:0806
9 schema:author Na0533cd0f1f24bbc89e4bdaea3d34e6b
10 schema:citation sg:pub.10.1038/nbt.3218
11 sg:pub.10.1038/nbt.3452
12 sg:pub.10.1186/s12896-015-0190-4
13 https://doi.org/10.1016/j.stem.2010.09.004
14 https://doi.org/10.1016/j.stem.2011.10.010
15 https://doi.org/10.1016/j.stem.2012.04.018
16 https://doi.org/10.1098/rstb.2015.0017
17 https://doi.org/10.1136/bmj.b2700
18 https://doi.org/10.2217/rme.11.28
19 https://doi.org/10.2217/rme.12.45
20 https://doi.org/10.5966/sctm.2013-0180
21 schema:datePublished 2017-12
22 schema:datePublishedReg 2017-12-01
23 schema:description BACKGROUND: Cellular-based therapies represent a platform technology within the rapidly expanding field of regenerative medicine and are distinct from conventional therapeutics-offering a unique approach to managing what were once considered untreatable diseases. Despite a significant increase in basic science activity within the cell therapy arena, alongside a growing portfolio of cell therapy trials and promising investment, the translation of cellular-based therapeutics from "bench to bedside" remains challenging, and the number of industry products available for widespread clinical use remains comparatively low. This systematic review identifies unique intrinsic and extrinsic barriers in the cell-based therapy domain. METHODS/DESIGN: Eight electronic databases will be searched, specifically Medline, EMBASE (OvidSP), BIOSIS & Web of Science, Cochrane Library & HEED, EconLit (ProQuest), WHOLIS WHO Library Database, PAIS International (ProQuest), and Scopus. Addition to this gray literature was searched by manually reviewing relevant work. All identified articles will be subjected for review by two authors who will decide whether or not each article passes our inclusion/exclusion criteria. Eligible papers will subsequently be reviewed, and key data extracted into a pre-designed data extraction scorecard. An assessment of the perceived impact of broad commercial barriers to the adoption of cell-based therapies will be conducted. These broad categories will include manufacturing, regulation and intellectual property, reimbursement, clinical trials, clinical adoption, ethics, and business models. This will inform further discussion in the review. There is no PROSPERO registration number. DISCUSSION: Through a systematic search and appraisal of available literature, this review will identify key challenges in the commercialization pathway of cellular-based therapeutics and highlights significant barriers impeding successful clinical adoption. This will aid in creating an adaptable, acceptable, and harmonized approach supported by apposite regulatory frameworks and pertinent expertise throughout the respective stages of the adoption cycle to facilitate the adoption of new products and technologies in the industry.
24 schema:genre research_article
25 schema:inLanguage en
26 schema:isAccessibleForFree true
27 schema:isPartOf N8df683f72ed4405197cac5dbbf5b2ae9
28 N946f736f4c8145a48880dc70e7714b8d
29 sg:journal.1046628
30 schema:name An assessment of the factors affecting the commercialization of cell-based therapeutics: a systematic review protocol
31 schema:pagination 120
32 schema:productId N40e6a51d1aff4a3b8c5e903d14811ad8
33 N99115560b846499fa520314250409429
34 Nf370a135738a4519b24dfd519d040d1c
35 Nf3c721e275254e97980d3c351bafe476
36 Nf54d41c977a44609aba0a826ed66f677
37 schema:sameAs https://app.dimensions.ai/details/publication/pub.1086339067
38 https://doi.org/10.1186/s13643-017-0517-4
39 schema:sdDatePublished 2019-04-11T12:40
40 schema:sdLicense https://scigraph.springernature.com/explorer/license/
41 schema:sdPublisher Nf4d9ef7a4c224159a104c5963c9cac4a
42 schema:url https://link.springer.com/10.1186%2Fs13643-017-0517-4
43 sgo:license sg:explorer/license/
44 sgo:sdDataset articles
45 rdf:type schema:ScholarlyArticle
46 N078f68aaa9f644889b705a07f7130d61 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
47 schema:name Humans
48 rdf:type schema:DefinedTerm
49 N0ef5047e04744ac0880c7176805e3edb rdf:first sg:person.01331422403.10
50 rdf:rest N6c580682a30044e2acb5ff0450100b55
51 N40e6a51d1aff4a3b8c5e903d14811ad8 schema:name doi
52 schema:value 10.1186/s13643-017-0517-4
53 rdf:type schema:PropertyValue
54 N4db8cf0ed3114db6a3df23ccecac45ec rdf:first sg:person.013276703300.52
55 rdf:rest N6d773d63b7a14e7292388ac8865f4e09
56 N63b85c25bdac48ec91efe53c832f0b33 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
57 schema:name Cost-Benefit Analysis
58 rdf:type schema:DefinedTerm
59 N66ae85417c7f4e8883b75aebc8158833 rdf:first sg:person.0665664476.45
60 rdf:rest rdf:nil
61 N6c580682a30044e2acb5ff0450100b55 rdf:first sg:person.0776251776.35
62 rdf:rest N8d733540b0fa46a09659807c136eed37
63 N6d773d63b7a14e7292388ac8865f4e09 rdf:first sg:person.0742155077.68
64 rdf:rest N7ab8bdf0219143e29ac374e2abd01d56
65 N7a03df0ffd634a02946c2a6f888398eb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
66 schema:name Systematic Reviews as Topic
67 rdf:type schema:DefinedTerm
68 N7ab8bdf0219143e29ac374e2abd01d56 rdf:first sg:person.0727523176.44
69 rdf:rest Ne57d82ef1eb340a3983b5e418d8c8b28
70 N8728243838fc4c94a8dcba96a5bb5c80 schema:affiliation https://www.grid.ac/institutes/grid.413735.7
71 schema:familyName Karp
72 schema:givenName Jeff
73 rdf:type schema:Person
74 N89928ef9038846f98a0ead607075ab68 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
75 schema:name Cell- and Tissue-Based Therapy
76 rdf:type schema:DefinedTerm
77 N8d733540b0fa46a09659807c136eed37 rdf:first sg:person.01245453273.36
78 rdf:rest N66ae85417c7f4e8883b75aebc8158833
79 N8df683f72ed4405197cac5dbbf5b2ae9 schema:volumeNumber 6
80 rdf:type schema:PublicationVolume
81 N946f736f4c8145a48880dc70e7714b8d schema:issueNumber 1
82 rdf:type schema:PublicationIssue
83 N99115560b846499fa520314250409429 schema:name dimensions_id
84 schema:value pub.1086339067
85 rdf:type schema:PropertyValue
86 Na0533cd0f1f24bbc89e4bdaea3d34e6b rdf:first sg:person.01213036105.17
87 rdf:rest Nb79644beab5749c6bdadcecd7655b212
88 Na62f324d1ff34757a65d792d27bf9a20 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Commerce
90 rdf:type schema:DefinedTerm
91 Naabef088fb7945f5933a84813ef76214 rdf:first sg:person.01104354070.41
92 rdf:rest Nfb6271b3ad3840cabb7bb570178af4be
93 Nb79644beab5749c6bdadcecd7655b212 rdf:first sg:person.01124552417.66
94 rdf:rest N4db8cf0ed3114db6a3df23ccecac45ec
95 Nbaae566006294f059f650e40dd314855 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Regenerative Medicine
97 rdf:type schema:DefinedTerm
98 Nc6c62394bbba4f6f82e937d08b2f8108 schema:name Flagship Ventures, Cambridge, USA
99 rdf:type schema:Organization
100 Ncb6d7aff8c2a4b5ea6d7ae5f179a76e1 rdf:first N8728243838fc4c94a8dcba96a5bb5c80
101 rdf:rest N0ef5047e04744ac0880c7176805e3edb
102 Nda4de503e4854eb69f80f58922f8c94d schema:affiliation Nc6c62394bbba4f6f82e937d08b2f8108
103 schema:familyName Cole
104 schema:givenName Doug
105 rdf:type schema:Person
106 Ne57d82ef1eb340a3983b5e418d8c8b28 rdf:first Nda4de503e4854eb69f80f58922f8c94d
107 rdf:rest Naabef088fb7945f5933a84813ef76214
108 Neb139a3fb06149fcac7c8cae25a6cf76 rdf:first sg:person.01214337563.35
109 rdf:rest Ncb6d7aff8c2a4b5ea6d7ae5f179a76e1
110 Nf370a135738a4519b24dfd519d040d1c schema:name pubmed_id
111 schema:value 28651620
112 rdf:type schema:PropertyValue
113 Nf3c721e275254e97980d3c351bafe476 schema:name nlm_unique_id
114 schema:value 101580575
115 rdf:type schema:PropertyValue
116 Nf4d9ef7a4c224159a104c5963c9cac4a schema:name Springer Nature - SN SciGraph project
117 rdf:type schema:Organization
118 Nf54d41c977a44609aba0a826ed66f677 schema:name readcube_id
119 schema:value b452225cade6e2e101d52639819905bf39792f7eba8b164f0134d220e662be57
120 rdf:type schema:PropertyValue
121 Nfb6271b3ad3840cabb7bb570178af4be rdf:first sg:person.01357145116.46
122 rdf:rest Neb139a3fb06149fcac7c8cae25a6cf76
123 anzsrc-for:08 schema:inDefinedTermSet anzsrc-for:
124 schema:name Information and Computing Sciences
125 rdf:type schema:DefinedTerm
126 anzsrc-for:0806 schema:inDefinedTermSet anzsrc-for:
127 schema:name Information Systems
128 rdf:type schema:DefinedTerm
129 sg:journal.1046628 schema:issn 2046-4053
130 schema:name Systematic Reviews
131 rdf:type schema:Periodical
132 sg:person.01104354070.41 schema:affiliation https://www.grid.ac/institutes/grid.425849.6
133 schema:familyName Bure
134 schema:givenName Kim
135 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01104354070.41
136 rdf:type schema:Person
137 sg:person.01124552417.66 schema:affiliation https://www.grid.ac/institutes/grid.11914.3c
138 schema:familyName Arshad
139 schema:givenName Zeeshaan
140 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01124552417.66
141 rdf:type schema:Person
142 sg:person.01213036105.17 schema:affiliation https://www.grid.ac/institutes/grid.4991.5
143 schema:familyName Pettitt
144 schema:givenName David
145 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01213036105.17
146 rdf:type schema:Person
147 sg:person.01214337563.35 schema:affiliation https://www.grid.ac/institutes/grid.168010.e
148 schema:familyName DiGiusto
149 schema:givenName David
150 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01214337563.35
151 rdf:type schema:Person
152 sg:person.01245453273.36 schema:affiliation https://www.grid.ac/institutes/grid.412347.7
153 schema:familyName Holländer
154 schema:givenName Georg
155 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01245453273.36
156 rdf:type schema:Person
157 sg:person.013276703300.52 schema:affiliation https://www.grid.ac/institutes/grid.5335.0
158 schema:familyName Davies
159 schema:givenName Benjamin
160 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013276703300.52
161 rdf:type schema:Person
162 sg:person.01331422403.10 schema:affiliation https://www.grid.ac/institutes/grid.38142.3c
163 schema:familyName Reeve
164 schema:givenName Brock
165 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01331422403.10
166 rdf:type schema:Person
167 sg:person.01357145116.46 schema:affiliation https://www.grid.ac/institutes/grid.4991.5
168 schema:familyName Dopson
169 schema:givenName Sue
170 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01357145116.46
171 rdf:type schema:Person
172 sg:person.0665664476.45 schema:affiliation https://www.grid.ac/institutes/grid.83440.3b
173 schema:familyName Brindley
174 schema:givenName David
175 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0665664476.45
176 rdf:type schema:Person
177 sg:person.0727523176.44 schema:affiliation https://www.grid.ac/institutes/grid.4991.5
178 schema:familyName French
179 schema:givenName Anna
180 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0727523176.44
181 rdf:type schema:Person
182 sg:person.0742155077.68 schema:affiliation https://www.grid.ac/institutes/grid.4991.5
183 schema:familyName Smith
184 schema:givenName James
185 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0742155077.68
186 rdf:type schema:Person
187 sg:person.0776251776.35 schema:affiliation https://www.grid.ac/institutes/grid.4991.5
188 schema:familyName Barker
189 schema:givenName Richard
190 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0776251776.35
191 rdf:type schema:Person
192 sg:pub.10.1038/nbt.3218 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011918031
193 https://doi.org/10.1038/nbt.3218
194 rdf:type schema:CreativeWork
195 sg:pub.10.1038/nbt.3452 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032721348
196 https://doi.org/10.1038/nbt.3452
197 rdf:type schema:CreativeWork
198 sg:pub.10.1186/s12896-015-0190-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031812111
199 https://doi.org/10.1186/s12896-015-0190-4
200 rdf:type schema:CreativeWork
201 https://doi.org/10.1016/j.stem.2010.09.004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022455401
202 rdf:type schema:CreativeWork
203 https://doi.org/10.1016/j.stem.2011.10.010 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011240838
204 rdf:type schema:CreativeWork
205 https://doi.org/10.1016/j.stem.2012.04.018 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036397370
206 rdf:type schema:CreativeWork
207 https://doi.org/10.1098/rstb.2015.0017 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011091196
208 rdf:type schema:CreativeWork
209 https://doi.org/10.1136/bmj.b2700 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015745369
210 rdf:type schema:CreativeWork
211 https://doi.org/10.2217/rme.11.28 schema:sameAs https://app.dimensions.ai/details/publication/pub.1069333383
212 rdf:type schema:CreativeWork
213 https://doi.org/10.2217/rme.12.45 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034651790
214 rdf:type schema:CreativeWork
215 https://doi.org/10.5966/sctm.2013-0180 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073577458
216 rdf:type schema:CreativeWork
217 https://www.grid.ac/institutes/grid.11914.3c schema:alternateName University of St Andrews
218 schema:name Docherty Gardens, KY7 5GA, Glenrothes, UK
219 University of St. Andrews School of Medicine, University of St. Andrews, St. Andrews, UK
220 rdf:type schema:Organization
221 https://www.grid.ac/institutes/grid.168010.e schema:alternateName Stanford University
222 schema:name Division of Cell Transplantation and Regenerative Medicine, University of Stanford, Stanford, USA
223 rdf:type schema:Organization
224 https://www.grid.ac/institutes/grid.38142.3c schema:alternateName Harvard University
225 schema:name Harvard Stem Cell Institute, Cambridge, USA
226 rdf:type schema:Organization
227 https://www.grid.ac/institutes/grid.412347.7 schema:alternateName University Children’s Hospital Basel
228 schema:name Department of Biomedicine, University of Basel and Basel University Children’s Hospital, Basel, Switzerland
229 Department of Paediatrics, University of Oxford, Oxford, UK
230 rdf:type schema:Organization
231 https://www.grid.ac/institutes/grid.413735.7 schema:alternateName Harvard–MIT Division of Health Sciences and Technology
232 schema:name Brigham and Women’s Hospital, Boston, USA
233 Harvard Medical School, Harvard University, Boston, USA
234 Harvard-MIT Division of Health Sciences and Technology, Cambridge, USA
235 rdf:type schema:Organization
236 https://www.grid.ac/institutes/grid.425849.6 schema:alternateName Sartorius (Germany)
237 schema:name Sartorius Stedim, Göttingen, Germany
238 rdf:type schema:Organization
239 https://www.grid.ac/institutes/grid.4991.5 schema:alternateName University of Oxford
240 schema:name Department of Paediatrics, University of Oxford, Oxford, UK
241 Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK
242 Said Business School, University of Oxford, Oxford, UK
243 The Oxford – UCL Centre for the Advancement of Sustainable Medical Innovation (CASMI), The University of Oxford, Oxford, UK
244 rdf:type schema:Organization
245 https://www.grid.ac/institutes/grid.5335.0 schema:alternateName University of Cambridge
246 schema:name Orthopedic Surgery Departement, University of Cambridge, Cambridge, UK
247 rdf:type schema:Organization
248 https://www.grid.ac/institutes/grid.83440.3b schema:alternateName University College London
249 schema:name Centre for Behavioral Medicine, UCL School of Pharmacy, University College London, London, UK
250 Department of Paediatrics, University of Oxford, Oxford, UK
251 Harvard Stem Cell Institute, Cambridge, USA
252 Said Business School, University of Oxford, Oxford, UK
253 The Oxford – UCL Centre for the Advancement of Sustainable Medical Innovation (CASMI), The University of Oxford, Oxford, UK
254 USCF-Stanford Center of Excellence in Regulatory Science and Innovation (CERSI), Stanford, USA
255 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...